been the subject of recent extensive reviews. J.2 They have been found to have a rapid, dose-dependent onset of action (1-4 minutes) and a duration of action of one-third to one-half that of equipotent doses of pancuronium. They exhibit rapid spontaneous recovery, minimal cumulation with repeated doses and absence of major cardiovascular side-effects.
patients. 7 This study was designed to compare larger equipotent doses of atracurium and vecuronium in short gynaecological procedures.
METHODS
Thirty women undergoing elective laparoscopy were studied. Any patient over 90 kg or with a history of renal, hepatic or neuromuscular disease, asthma, hypersensitivity to anaesthetic agents or who was not ASA I or 11, was excluded. Written informed consent was obtained from each patient the night before operation and the study was approved by the Hospital Ethical Committee.
Anaesthetic management
All patients received premedication with papaveretum 0.2 mg/kg and hyoscine 0.004 mg/kg IM one hour preoperatively. On arrival in theatre, an intravenous infusion oflactated Ringer's solution was commenced via an indwelling cannula in the left arm and a blood pressure cuff and digital pulse monitor were placed on the same arm. The neuromuscular monitoring equipment was attached to the right arm.
Anaesthesia was induced with thiopentone 2.5% solution injected into the running infusion until the eyelash reflex was lost. Anaesthesia was then maintained by spontaneous inhalation of nitrous oxide (3 litres/m in), oxygen (1 litre/min) and halothane 1 % via a circle absorber system until control blood pressure, pulse and train-of-four recordings had been obtained. Each patient then received, on a random basis, either atracurium 0.4 mg/kg or vecuronium 0.1 mg/kg representing a 2 X ED95 dose of each relaxant. Fifteen patients received each drug. Each relaxant dose was diluted to 5 ml with normal saline and the anaesthetist did not know which drug was given. Respiration was assisted manually as paralysis developed.
Laryngoscopy was performed at one-minute intervals from the time of relaxant injection. Intubating conditions at each time were scored according to a modification of the scheme of Lund 1 -cords visible but moving; 2 -cords visible and still, but patient coughs on intubation; 3 -cords visible and still, patient does not cough on intubation. Once a score of 2 was reached, intubation was performed using a Magill cuffed endotracheal tube of appropriate size. Anaesthesia was continued by controlled ventilation with the C02 absorber turned off. Fresh gas flows were adjusted to 80 mllkg to maintain approximate normocarbia. Halothane concentration was decreased to 0.5%. Inspired oxygen concentration was measured with a fuel cell analyser. Blood pressure and pulse rate were measured using a mercury manometer and digital pulse monitor prior to induction, before and after injection of the relaxant, and at five-minute intervals for the duration of the procedure.
At the completion of surgery, neostigmine 2.5 mg and atropine 1.2 mg were administered. When the anaesthetist judged, on clinical grounds, that adequate spontaneous respiration had returned, the patient was extubated.
The condition of the patient at this time was scored as: 1 -just adequate muscle power; 2 -adequate but not full muscle power; 3 -full muscle power.
The patients were then transferred to the recovery ward where they were closely observed for sixty minutes. Blood pressure, pulse rate, respiratory rate and ability to maintain a head lift for five seconds were recorded at ten-minute intervals. The time at which the recovery staff considered the patient ready to return to the ward was noted (Time to Full Recovery).
Neuromuscular monitoring
Neuromuscular monitoring was accomplished by the application of a supramaximal train-of-four stimulation to the ulnar nerve at the right wrist using skin electrodes. The force of adduction of the thumb was recorded by means of strain gauges adherent to a flexible metal strip to which the thumb was attached, according to the method described by Fiore et al. 9 The signal was displayed and recorded on an EMI SE3006 U-V Chart Recorder. The monitoring equipment was positioned so that the anaesthetist could not see the responses to stimulation, therefore he based his actions solely on clinical grounds.
Following induction of anaesthesia, a control recording was obtained. After administration of the relaxant, recordings were made every fifteen seconds for four minutes, every two minutes until the neostigmine and atropine were administered and then every fifteen seconds again until the patient was transferred to the recovery trolley prior to extubation. As this occurred at variable times following reversal of the neuromuscular block, the data concerning block offset was not suitable for statistical analysis.
Surgical technique
Laparoscopy was performed via a peri-umbilical incision following inflation of the abdomen with carbon dioxide via an insufflating needle. The surgeon's assessment of abdominal wall relaxation was recorded as 'poor', 'adequate' or 'excellent'.
Statistical analysis
The patient group characteristics, mean time to onset of block, ratios of first twitch height to control twitch height, and fourth twitch height to first twitch height of the train-of-four, mean times to 90% and 100% twitch depression, mean time between reversal administration and extubation and mean time to full recovery were compared using Student's t-test. The number of patients intubated at one and two minutes after relaxant administration and those remaining intubated at times following reversal were compared using the chi-squared test. The There were no significant differences between the characteristics of the two patient groups ( Table 1) . Clinical assessments (a) Intubation. Table 2 shows the cumulative number of patients intubated at one and two minutes. There was no significant difference between the two groups and all patients were intubated by two minutes. (b) Cardiovascular recordings. As shown in Table 3 , six patients in the vecuronium group and five in the atracurium group showed a fall in systolic blood pressure of greater than 15% of the preoperative value at some time intraoperatively. None showed a fall greater than 30%. One patient in each group exhibited a sinus bradycardia of approximately 50 bpm. This was associated with mild hypotension only in the patient in the vecuronium group. There was no other intraoperative dysrhythmia in either group.
(c) Extubation. The extubation scores in both groups were virtually identical indicating a similar clinical state at the time the decision was made to extubate. The mean time elapsed between administration of neostigmine and atropine and extubation (Table  3) . This difference was not significant. The survival curves for the number of patients remaining intubated against time from reversal administration are shown in Figure 1 . There is no significant difference between them. Two patients in the vecuronium group (duration of procedures 18 and 22 minutes) and one in the atracurium group (duration 13 minutes) were given further doses of reversal on clinical grounds. Muscle power returned rapidly in each of these patients. (d) Recovery. Mild transient hypotension (> 15%) was seen in one patient in the vecuronium group. There were no dysrhythmias in either group. There was no significant difference between the mean times to full recovery (after arrival in the recovery ward) of 23 (SD 10) minutes for the vecuronium group and 27 (SD 14) minutes for the atracurium group.
(e) Surgical relaxation. All patients were rated 'adequate' or 'excellent' by the surgeons in terms of abdominal wall muscle relaxation.
Neuromuscular monitoring
Complete data was not available in five of the atracurium group due to technical difficulties.
(a) Onset of block. The mean times taken to the first perceptible depression of twitch height were 1.15 (SD 0.34) minutes in the vecuronium group and 0.90 (SD 0.35) minutes in the atracurium group and these were not significantly different. All patients achieved 100% twitch depression (maximum block). The mean times to 90% and 100% twitch depression respectively were 2.60 (SD 0.71) and 3.10 (SD 0.77) minutes for the vecuronium group and 2.42 (SD 0.81) and 2.90 (SD 0.80) minutes for the atracurium group. These differences were not significant. Scrutiny of the ratio of the first twitch height at 1, 2, 3 and 4 minutes after relaxant administration to the relevant control twitch height (T 1 /TC ratio) and of the fourth twitch height to first twitch height (T4/Tl ratio) showed a more rapid development of the block in the atracurium group, significant at one and two minutes. (b) Spontaneous recovery. The induction-reversal time varied between 13 and 37 minutes. As this study was not designed to investigate recovery in detail and the neostigmine and atropine were administered in the usual manner at the end of the surgical procedure, not all patients achieved the endpoints of first or 10% recovery of twitch prior to reversal. In the vecuronium group 6/15 patients had shown some spontaneous recovery. Mean time to first perceptible spontaneous recovery (n = 6) was 23.1 (SD 3.3) minutes and time to 10% recovery (n = 5) was 25.5 (SD 2.2) minutes. In the atracurium group only 2/15 patients achieved any recovery with a mean time to first twitch of 28 minutes. Neither patient achieved 10% recovery prior to administration of reversal. There was no significant difference in the times to first recovery or the number showing recovery in the two groups.
DISCUSSION
Equipotent doses of each relaxant drug were chosen so that a direct comparison could be made. Neuromuscular monitoring clearly showed an initially more rapid development of the block with atracurium, with regard to both first twitch depression (T 1 /TC ratio) and degree of fade (T4/Tl ratio). This was significant at 1 and 2 minutes. Pearce et al. have also shown that atracurium causes more train-of-four fade than vecuronium during block onset and additionally that both drugs exhibited significantly more fade during block offset than onset. 12 It is likely that single twitch depression and fade result from the neuromuscular blocking drug binding to different sites within the neuromuscular junction. Bowman suggests that single twitch response is a function of blockade of post-junctional receptors and that fade represents blockade of pre-junctional cholinoreceptors impairing transmitter mobilisation and/or release. 13, 14 This, in turn, exaggerates the effects of the post-junctional block. The pre-junctional effect appears to increase in importance with increasing stimulation frequency. Recent work by Otagiri and Sokoll l5 and Wali '6 provides evidence for such a pre-junctional effect of atracurium. A second population of pre-junctional receptors, located at the first node of Ranvier mediates depolarisation of the axonal membrane and may give rise to repetitive firing of the nerve fibre.
Despite this initial difference in block development, the onset times to 90% and 100% block were similar for the two drugs. The onset time to maximum (100%) block was approximately three minutes, similar to that found by Bencini and Newton. '7 In a dose-response study of atracurium and vecuronium, Healy et al. found no significant difference in times to maximum depression of the evoked compound action potential of adductor pollicis when equipotent doses were compared. '8 Their mean times, when using similar doses to this study, were however shorter (2.31 (SD 0.14) minutes for atracurium 0.5 mg/kg and 2.42 (SD 0.07) minutes for vecuronium 0.1 mg/kg) which may reflect a difference between electromyographic and mechanical methods of monitoring neuromuscular blockade.
Clinically, the onset of good intubating conditions was similar in both groups. All patients were intubated by two minutes and over half of each group could be intubated at one minute. In neither group was the onset as rapid as that found with succinylcholine. '9 ,2o Mirakhur et al. using vecuronium 0.1 mg/kg were able to intubate 40% of their patients at 60 seconds and 90% by 90 seconds. 21 Schiller and Feldman compared intubating conditions with atracurium 0.6 mg/kg, vecuronium 0.1 mg/kg and pancuronium 0.1 mg/kg. They found a statistically significant earlier onset of satisfactory intubating conditions with this larger dose of atracurium than with the other two agents, but no difference between vecuronium and pancuronium in this respect. 22 Our anaesthetists were unable to distinguish clinically between the two relaxants.
The rapid onset of good intubating conditions was paralleled by developing neuromuscular blockade as measured by nerve stimulation at the wrist. In this study 9/15 patients in the vecuronium group were intubated at one minute with a mean T lITC ratio of 0.85 and the 8/15 patients in the atracurium group with a ratio of 0.54, confirming that satisfactory intubating conditions do not require maximum neuromuscular block. Bencini and Newton, using vecuronium, showed that depression of twitch tension of the adductor pollicis developed concommitantly with the establishment of good intubating conditions. 17 They were able to intubate all the patients in their group showing 50-60% neuromuscular block at the time of attempted intubation although optimal conditions required 100% block.
Spontaneous recovery occurred in only a small number of our patients prior to administration of neostigmine and atropine, reflecting the short duration of the surgical procedures. The apparent difference in recovery between the two groups was not significant. Foldes et al. showed no significant difference in clinical duration of action (mean time to 25% recovery) of atracurium 0.4 mg/kg (39 (SO 1.6) minutes) and vecuronium 0.1 mg/kg (38 (SO 1.9) minutes). 23 The recovery rate (time from 25% to 75% recovery) and duration of subsequent maintenance doses were also similar, but the time to maximal recovery of twitch height after the last dose was significantly shorter with vecuronium. Robertson et at. compared 1 X E090 doses of atracurium (188 Ilg/kg) and vecuronium (43 Ilg/kg) and found a significantly more rapid onset time, shorter duration of action and faster recovery rate with vecuronium. 24 However, at 3 X E090 doses there was no significant difference between the drugs. These doses are the usual limits of the clinically useful range and vecuronium appears to have an advantage in the lower part of this range. No serious cardiovascular disturbances were seen in any patient although the incidence of mild hypotension was greater than expected on the basis of their known cardiovascular stability. The use of halothane 0.5-1.0% as part of the anaesthetic technique may have contributed to this. Bradycardia has been reported in association with both atracurium 25 ,26 and vecuronium 27 and appears to be due to an unmasking of the vagal effects of other agents, especially the narcotics and halothane, No evidence of histamine release was noted in any patient.
In conclusion, atracurium was shown to have an initially greater first twitch depression and more fade during the onset of neuromuscular block than vecuronium, but the times to attain maximum block were similar. There were no clinical differences between the two drugs. In these doses, both agents are suitable for surgery of 20-30 minutes' duration, but antagonism of the neuromuscular block is required.
